MedTrace Logo

Arnica Montana and Bellis Perennis for Prevention of Seroma After Mastectomy

NCT03512639 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2018-05-07

No results posted yet for this study

Summary

Arnica montana and Bellis perennis for Prevention of Seroma Following Mastectomy.

Conditions

  • Seroma

Interventions

DRUG

Homeopathic Medication

Homeopathic medication (Arnica montana and the Bellis perennis) were given to women in the study group following mastectomy and reconstruction to reduce post operative seroma

DRUG

Placebo

placebo was given to women in the control group following mastectomy and reconstruction to reduce post operative seroma

Sponsors & Collaborators

  • Shaare Zedek Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2017-08-01
Completion
2018-04-01

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03512639 on ClinicalTrials.gov